Cite
HARVARD Citation
Mathias, S. et al. (2016). A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents. Pediatric blood & cancer. 63 (7), pp. 1232-1237. [Online].